Abivax S.A. (ABVX) has a consensus analyst rating of Buy, based on 9 analysts covering the stock. Of those, 9 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for ABVX is $145.67, representing a +15.8% upside from the current price of $125.8. Price targets range from a low of $110.00 to a high of $176.00.
